You are here:
Dear Doctor Letter (Rote-Hand-Brief) on Aclasta®: Reports on renal dysfunction and renal failure
2010.03.12
Active substance: zoledronic acid
Additional safety information on reports on renal dysfunction and renal failure with Aclasta®.
Download DHPC / Information letter , Download_VeroeffentlichtAm_EN